Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 1/2014

01-01-2014 | Research Paper

Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth

Authors: Dirk Weinspach, Bastian Seubert, Susanne Schaten, Katja Honert, Susanne Sebens, Peter Altevogt, Achim Krüger

Published in: Clinical & Experimental Metastasis | Issue 1/2014

Login to get access

Abstract

Expression of the L1 cell adhesion molecule (L1CAM) is frequently increased in cancer patients compared to healthy individuals and also linked with bad prognosis of solid tumours. Previously, we could show that full-length L1CAM promotes metastasis formation via up-regulation of gelatinolytic activity in fibrosarcoma. In this study, we aimed to extend this finding to haematogenous malignancies and carcinomas, and to specifically elucidate the impact of L1CAM on major steps of the metastatic cascade. In a well-established T-cell lymphoma spontaneous metastasis model, silencing of L1CAM significantly improved survival of the mice, while intradermal tumour growth remained unaltered. This correlated with significantly decreased spontaneous metastasis formation. L1CAM suppression abrogated the metastatic potential of T-cell lymphoma as well as carcinoma cells as demonstrated by reduced migration and invasion in vitro and reduced formation of experimental metastasis in vivo. At the molecular level, silencing of L1CAM led to reduced expression of gelatinases MMP-2 and -9 in vitro and decreased gelatinolytic activity in primary tumours and metastases in vivo. In accordance, knock down of L1CAM had similar suppressive effects on migration, invasion and in vivo-gelatinolytic activity as treatment with the specific gelatinase inhibitor SB-3CT. This newly discovered impact of L1CAM on distinct steps of the metastatic cascade and MMP activity highlights the potential of possible L1CAM-directed therapies to inhibit metastatic spread.
Appendix
Available only for authorised users
Literature
1.
2.
Fidler IJ (2003) The pathogenesis of cancer metastasis: the “seed and soil” hypothesis revisited. Nat Rev Cancer 3:453–458PubMedCrossRef
3.
4.
Pals ST, de Gorter DJJ, Spaargaren M (2007) Lymphoma dissemination: the other face of lymphocyte homing. Blood 110:3102–3111PubMedCrossRef
5.
Noël A, Gutiérrez-Fernández A, Sounni NE et al (2012) New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment. Front Pharmacol 3:140PubMedCentralPubMed
6.
Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9–34PubMedCrossRef
7.
Mook ORF, Frederiks WM, Van Noorden CJF (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705:69–89PubMed
8.
Zeng ZS, Cohen AM, Guillem JG (1999) Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 20:749–755PubMedCrossRef
9.
Dufour A, Zucker S, Sampson NS et al (2010) Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides. J Biol Chem 285:35944–35956PubMedCrossRef
10.
11.
Chetty C, Vanamala SK, Gondi CS et al (2012) MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 24:549–559PubMedCentralPubMedCrossRef
12.
Gerg M, Kopitz C, Schaten S et al (2008) Distinct functionality of tumor cell-derived gelatinases during formation of liver metastases. Mol Cancer Res 6:341–351PubMedCrossRef
13.
Brown S, Bernardo M, Li Z-H (2000) Potent and selective mechanism-based inhibition of gelatinases. J Am Chem Soc 122:6799–6800CrossRef
14.
Krüger A, Arlt MJE, Gerg M et al (2005) Antimetastatic activity of a novel mechanism-based gelatinase inhibitor. Cancer Res 65:3523–3526PubMedCrossRef
15.
Westermarck J, Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13:781–792PubMed
16.
Munshi HG, Stack MS (2006) Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25:45–56PubMedCrossRef
17.
18.
Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118–132PubMedCrossRef
19.
Kiefel H, Bondong S, Hazin J et al (2012) L1CAM: a major driver for tumor cell invasion and motility. Cell Adh Migr 6:374–384PubMedCrossRef
20.
21.
Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze’ev A (2008) L1-CAM in cancerous tissues. Expert Opin Biol Ther 8:1749–1757PubMedCrossRef
22.
Raveh S, Gavert N, Ben-Ze’ev A (2009) L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 282:137–145PubMedCrossRef
23.
Fogel M, Gutwein P, Mechtersheimer S et al (2003) L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362:869–875PubMedCrossRef
24.
Schäfer H, Geismann C, Heneweer C et al (2012) Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent. Carcinogenesis 33:84–93PubMedCrossRef
25.
Gavert N, Sheffer M, Raveh S et al (2007) Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 67:7703–7712PubMedCrossRef
26.
Gavert N, Ben-Shmuel A, Lemmon V et al (2010) Nuclear factor-kappaB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells. J Cell Sci 123:2135–2143PubMedCrossRef
27.
Gavert N, Vivanti A, Hazin J et al (2011) L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9:14–24PubMedCrossRef
28.
Thies A, Schachner M, Moll I et al (2002) Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 38:1708–1716PubMedCrossRef
29.
Arlt MJE, Novak-Hofer I, Gast D et al (2006) Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res 66:936–943PubMedCrossRef
30.
Fischer E, Grünberg J, Cohrs S et al (2012) L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer. Int J Cancer 130:2715–2721PubMedCrossRef
31.
Knogler K, Grünberg J, Zimmermann K et al (2007) Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis. Clin Cancer Res 13:603–611PubMedCrossRef
32.
Hai J, Zhu C-Q, Bandarchi B et al (2012) L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer. Clin Cancer Res 18:1914–1924PubMedCrossRef
33.
Hung S-C, Wu I-H, Hsue S-S et al (2010) Targeting l1 cell adhesion molecule using lentivirus-mediated short hairpin RNA interference reverses aggressiveness of oral squamous cell carcinoma. Mol Pharm 7:2312–2323PubMedCrossRef
34.
Krüger A, Schirrmacher V, von Hoegen P (1994) Scattered micrometastases visualized at the single-cell level: detection and re-isolation of lacZ-labeled metastasized lymphoma cells. Int J Cancer 58:275–284PubMedCrossRef
35.
Soneoka Y, Cannon PM, Ramsdale EE et al (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 23:628–633PubMedCentralPubMedCrossRef
36.
Yee JK, Miyanohara A, LaPorte P et al (1994) A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 91:9564–9568PubMedCrossRef
37.
Kopitz C, Anton M, Gansbacher B, Krüger A (2005) Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression in the host. Cancer Res 65:8608–8612PubMedCrossRef
38.
Krüger A, Umansky V, Rocha M et al (1994) Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84:3166–3174PubMed
39.
Arlt M, Kopitz C, Pennington C et al (2002) Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res 62:5543–5550PubMed
40.
Wolterink S, Moldenhauer G, Fogel M et al (2010) Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma. Cancer Res 70:2504–2515PubMedCrossRef
41.
Gast D, Riedle S, Riedle S et al (2005) L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 115:658–665PubMedCrossRef
42.
Gast D, Riedle S, Issa Y et al (2008) The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 27:1281–1289PubMedCrossRef
43.
Zhang H, Wong CCL, Wei H et al (2012) HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene 31:1757–1770PubMedCentralPubMedCrossRef
44.
Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRef
45.
Luzzi KJ, MacDonald IC, Schmidt EE et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873PubMedCrossRef
46.
Sebens Müerköster S, Werbing V, Sipos B et al (2007) Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26:2759–2768PubMedCrossRef
47.
Stoeck A, Gast D, Sanderson MP et al (2007) L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 104:461–469PubMedCrossRef
48.
Bergmann F, Wandschneider F, Sipos B et al (2010) Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma. Oncol Rep 24:909–915PubMed
49.
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009PubMedCrossRef
50.
Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8:629–642PubMedCrossRef
51.
Björklund M, Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755:37–69PubMed
52.
Gavert N, Conacci-Sorrell M, Gast D et al (2005) L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168:633–642PubMedCrossRef
53.
Tsutsumi S, Morohashi S, Kudo Y et al (2011) L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J Surg Oncol 103:669–673PubMedCrossRef
54.
Zecchini S, Bianchi M, Colombo N et al (2008) The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res 68:1110–1118PubMedCrossRef
Metadata
Title
Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth
Authors
Dirk Weinspach
Bastian Seubert
Susanne Schaten
Katja Honert
Susanne Sebens
Peter Altevogt
Achim Krüger
Publication date
01-01-2014
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 1/2014
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-013-9613-6

Other articles of this Issue 1/2014

Clinical & Experimental Metastasis 1/2014 Go to the issue

Research Paper

Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model

Research Paper

Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways

Research Paper

Prolonged survival following aggressive treatment for metastatic breast cancer in the spine

Research Paper

Tumour growth stimulation following partial hepatectomy in mice is associated with increased upregulation of c-Met

Research Paper

Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain

Research Paper

Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits